EP2715359A4 - Methods and compositions for therapeutic drug monitoring and dosing by point-of-care pharmacokinetic profiling - Google Patents

Methods and compositions for therapeutic drug monitoring and dosing by point-of-care pharmacokinetic profiling

Info

Publication number
EP2715359A4
EP2715359A4 EP12792802.6A EP12792802A EP2715359A4 EP 2715359 A4 EP2715359 A4 EP 2715359A4 EP 12792802 A EP12792802 A EP 12792802A EP 2715359 A4 EP2715359 A4 EP 2715359A4
Authority
EP
European Patent Office
Prior art keywords
dosing
care
compositions
methods
point
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP12792802.6A
Other languages
German (de)
French (fr)
Other versions
EP2715359A1 (en
Inventor
Vuong Ngoc Trieu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Autotelic LLC
Original Assignee
STRING THERAPEUTICS Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by STRING THERAPEUTICS Inc filed Critical STRING THERAPEUTICS Inc
Publication of EP2715359A1 publication Critical patent/EP2715359A1/en
Publication of EP2715359A4 publication Critical patent/EP2715359A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
EP12792802.6A 2011-05-30 2012-05-30 Methods and compositions for therapeutic drug monitoring and dosing by point-of-care pharmacokinetic profiling Withdrawn EP2715359A4 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201161491268P 2011-05-30 2011-05-30
US201161514488P 2011-08-03 2011-08-03
US201161526950P 2011-08-24 2011-08-24
US201161533250P 2011-09-11 2011-09-11
US201161577008P 2011-12-17 2011-12-17
US201261606371P 2012-03-03 2012-03-03
US201261615312P 2012-03-25 2012-03-25
US201261635730P 2012-04-19 2012-04-19
PCT/US2012/039993 WO2012166795A1 (en) 2011-05-30 2012-05-30 Methods and compositions for therapeutic drug monitoring and dosing by point-of-care pharmacokinetic profiling

Publications (2)

Publication Number Publication Date
EP2715359A1 EP2715359A1 (en) 2014-04-09
EP2715359A4 true EP2715359A4 (en) 2015-01-21

Family

ID=47259824

Family Applications (1)

Application Number Title Priority Date Filing Date
EP12792802.6A Withdrawn EP2715359A4 (en) 2011-05-30 2012-05-30 Methods and compositions for therapeutic drug monitoring and dosing by point-of-care pharmacokinetic profiling

Country Status (6)

Country Link
EP (1) EP2715359A4 (en)
JP (2) JP6184943B2 (en)
CN (1) CN104160274A (en)
AU (2) AU2012262322B2 (en)
CA (1) CA2837331A1 (en)
WO (1) WO2012166795A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20135189L (en) 2013-02-28 2014-08-29 iStoc Oy Portable lateral test result reader
WO2015081115A1 (en) * 2013-11-27 2015-06-04 Companion Dx Reference Lab, Llc Systems and methods for optimizing drug therapies
EP3126827A4 (en) * 2014-04-04 2017-11-15 Autotelic LLC Methods, devices, and reagents for monitoring paclitaxel concentration in plasma for pharmacokinetic-guided dosing of paclitaxel
US9714953B2 (en) 2014-04-04 2017-07-25 Autotelic Llc Methods, devices, and reagents for monitoring paclitaxel concentration in plasma for pharmacokinetic-guided dosing of paclitaxel
CA2956899A1 (en) * 2014-06-08 2015-12-17 Autotelic Llc Fixed dose combination for pain relief without edema
US20160008371A1 (en) * 2014-07-14 2016-01-14 Autotelic Llc Fixed dose combination for pain relief without edema
WO2016057679A1 (en) * 2014-10-09 2016-04-14 LuminaCare Solutions Inc. Personalized antibiotic dosing platform
WO2016115057A1 (en) * 2015-01-13 2016-07-21 Autotelic Llc Fixed dose combination for pain relief without edema
KR20160098029A (en) * 2015-01-13 2016-08-18 오토텔릭 엘엘씨 Method for individualized drug therapy
CN104899458B (en) * 2015-06-16 2017-09-15 中国环境科学研究院 Evaluate the QSAR toxicity prediction methods of nano-metal-oxide health effect
TW201718656A (en) 2015-10-07 2017-06-01 奧托德里克有限公司 Antibody-based affinity reagents for binding paclitaxel
US20200306211A1 (en) * 2015-11-30 2020-10-01 Pharnext Method for adapting doses of combination therapies
US9989543B2 (en) 2016-01-11 2018-06-05 Autotelic, Llc Composition, device, and method for detecting olmesartan and improving compliance in treating hypertension
US11802879B2 (en) 2016-03-02 2023-10-31 Waters Technologies Corporation Identification and quantification of conjugated peptides in antibody drug conjugates by mass spectrometry
UA126379C2 (en) 2016-04-15 2022-09-28 Баксалта Інкорпорейтед Method and device for providing a pharmacokinetic dosage regimen for medicinal products
US10896749B2 (en) 2017-01-27 2021-01-19 Shire Human Genetic Therapies, Inc. Drug monitoring tool
CN108593828A (en) * 2018-02-23 2018-09-28 李水军 Blood plasma prepares the detection method of drug and toxic content in card

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004091506A2 (en) * 2003-04-10 2004-10-28 Ivax Research, Inc. Taxane-based compositions and methods of use
US20100226966A1 (en) * 2009-03-03 2010-09-09 Daddona Peter E Method for transdermal controlled release drug delivery

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH075174A (en) * 1993-06-18 1995-01-10 Nippon Steel Corp High detectibility immunoassay
US6594168B2 (en) * 1997-05-30 2003-07-15 Micron Technology, Inc. 256 Meg dynamic random access memory
CA2346131C (en) * 1998-11-04 2013-01-15 Pharmacia & Upjohn Company Method for improving the pharmacokinetics of tipranavir
JP2003523940A (en) * 1999-05-11 2003-08-12 オーソ−マクネイル ファーマシューティカル インコーポレイテッド Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration
US20050054942A1 (en) * 2002-01-22 2005-03-10 Melker Richard J. System and method for therapeutic drug monitoring
EP1461029A1 (en) * 2001-12-28 2004-09-29 Ivax Research, Inc. Taxane based compositions and methods of use
AU2003214560A1 (en) * 2002-04-19 2003-11-03 Pfizer Products Inc. Test for measurement of therapeutic drug levels
JP2005523510A (en) * 2002-04-19 2005-08-04 インターナショナル・ビジネス・マシーンズ・コーポレーション Microprocessor and method for managing its power
KR100533458B1 (en) * 2002-07-20 2005-12-07 대화제약 주식회사 Composition for solubilization of paclitaxel and preparation method thereof
WO2005074633A2 (en) * 2004-02-03 2005-08-18 The Regents Of The University Of Michigan Compositions and methods for characterizing, regulating, diagnosing, and treating cancer
US20060024768A1 (en) * 2004-07-29 2006-02-02 Saladax Biomedical, Inc. Taxol immunoassay
US7638291B2 (en) * 2004-10-25 2009-12-29 Seradyn, Inc. Immunoassays for topiramate
KR101381331B1 (en) * 2005-05-09 2014-04-04 테라노스, 인코포레이티드 Point-of-care fluidic systems and uses thereof
WO2007058896A2 (en) * 2005-11-10 2007-05-24 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Materials and methods for abcb1 polymorphic variant screening, diagnosis, and treatment
CA2644110A1 (en) * 2006-03-03 2007-09-13 Elan Pharmaceuticals, Inc. Methods of treating inflammatory and autoimmune diseases with natalizumab
CN102323984A (en) * 2006-03-30 2012-01-18 陶氏环球技术有限责任公司 Be used to monitor and analyze the method and system of complying with of body innerlich anwenden scheme
JP5671523B2 (en) * 2009-04-30 2015-02-18 パーデュー・リサーチ・ファウンデーションＰｕｒｄｕｅ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ Ion production using wet porous materials
CA2768488A1 (en) * 2009-07-17 2011-01-20 Myriad Genetics, Inc. Method of assaying 5-fu

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004091506A2 (en) * 2003-04-10 2004-10-28 Ivax Research, Inc. Taxane-based compositions and methods of use
US20100226966A1 (en) * 2009-03-03 2010-09-09 Daddona Peter E Method for transdermal controlled release drug delivery

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2012166795A1 *

Also Published As

Publication number Publication date
AU2016277632A1 (en) 2017-01-19
WO2012166795A1 (en) 2012-12-06
EP2715359A1 (en) 2014-04-09
AU2012262322B2 (en) 2016-11-03
JP6184943B2 (en) 2017-08-23
CN104160274A (en) 2014-11-19
AU2012262322A1 (en) 2014-01-23
JP2014518375A (en) 2014-07-28
CA2837331A1 (en) 2012-12-06
JP2017207508A (en) 2017-11-24

Similar Documents

Publication Publication Date Title
EP2715359A4 (en) Methods and compositions for therapeutic drug monitoring and dosing by point-of-care pharmacokinetic profiling
AP3864A (en) Pharmaceutical composition
SI2776416T1 (en) Pharmaceutical compounds
EP2756855A4 (en) Drug injecting device
IL230861A (en) Fast dissolving pharmaceutical composition
GB201118232D0 (en) Pharmaceutical composition
EP2702989A4 (en) Stable pharmaceutical composition
EP2767257A4 (en) Articulator
HK1201534A1 (en) Pharmaceutical compounds
HK1189158A1 (en) Pharmaceutical composition
GB201119799D0 (en) Pharmaceutical compounds
GB2525835B (en) Pharmaceutical agent
EP2731610A4 (en) Pharmaceutical combination
GB201113163D0 (en) Pharmaceutical compounds
GB201118876D0 (en) Pharmaceutical compounds
EP2727593A4 (en) Nicorandil-containing pharmaceutical composition
HK1174525A1 (en) Articulator
EP2711010A4 (en) Pharmaceutical composition
HUP1100444A2 (en) Pharmaceutical composition
BR112013022907A2 (en) pharmaceutical composition
PL2709470T3 (en) Tobacco dosing system
PL2709599T3 (en) Pharmaceutical composition comprising drotaverine
HUP1100445A2 (en) Pharmaceutical composition
GB201108234D0 (en) Pharmaceutical agent
GB201119796D0 (en) Pharmaceutical comopounds

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20140102

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20150105

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/00 20060101ALI20141218BHEP

Ipc: G01N 33/543 20060101AFI20141218BHEP

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: AUTOTELIC LLC

17Q First examination report despatched

Effective date: 20160712

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20180825